Cancer Genetics expands marketshare in immuno-oncology focused clinical trials
Cancer Genetics announced the company is actively testing and providing data for 12 Immuno-Oncology clinical trials and 3 academic collaborations. The trials focus on solid tumors including lung, ovarian, head and neck, breast, urothelial and blood cancers including lymphomas and multiple myeloma. May 04, 2016